BPI-371153, an orally bioavailable small molecule PD-L1 inhibitor

被引：0

作者：

Wang, Yiqian ^{[1
]}

Jing, Xiangyan ^{[1
]}

Chen, Hong ^{[1
]}

Zhang, Huijuan ^{[1
]}

Ma, Tianyi ^{[1
]}

Zhang, Yao ^{[1
]}

Zhang, Chunhui ^{[1
]}

Zhang, Guangzhi ^{[1
]}

Liu, Xiangyong ^{[1
]}

Yan, Dan ^{[1
]}

Guo, Jing ^{[1
]}

Lan, Hong ^{[1
]}

Wang, Jiabing ^{[1
]}

Ding, Lieming ^{[2
]}

机构：

[1] Betta Pharmaceut Co LTD, Beijing, Peoples R China

[2] Betta Pharmaceut Co LTD, Hangzhou, Peoples R China

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5444

引用

页数：2

共 50 条

[21] NOVEL GUT-RESTRICTED SMALL MOLECULE INHIBITOR OF PD-L1 FOR TARGETING GI CANCERS
Sivanandhan, Dhanalakshmi
Rajagopal, Sridharan
Gajendran, Chandru
Naveen, Sadhu M.
Zainuddin, Mohammed
Gosu, Ramachandraiah
Rastelli, Luca
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1440 - A1440
[22] CHARACTERIZATION OF HZ-G206: A POTENT AND ORAL SMALL MOLECULE PD-L1 INHIBITOR
Wu, Yizhe
Liu, Xingguo
Jin, Xinxin
Huang, Jinglai
Zhou, Xinglu
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A478 - A478
[23] Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and Degradation
Wang, Tianyu
Cai, Shi
Cheng, Yao
Zhang, Wanheng
Wang, Minmin
Sun, Huiyong
Guo, Binghua
Li, Zheng
Xiao, Yibei
Jiang, Sheng
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (05) : 3879 - 3893
[24] NOVEL, BRAIN PENETRANT SMALL MOLECULE INHIBITOR OF PD-L1 FOR TARGETING GLIOBLASTOMA AND BRAIN METASTASIS
Sivanandhan, Dhanalakshmi
Rajagopal, Sridharan
Rajagopal, Sridharan
Gajendran, Chandru
Sadhu, M. Naveen
Zainuddin, Mohammed
Gosu, Ramachandraiah
Rastelli, Luca
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1430 - A1430
[25] Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor
Koblish, Holly K.
Wu, Liangxing
Wang, Liang-Chuan S.
Liu, Phillip C. C.
Wynn, Richard
Rios-Doria, Jonathan
Spitz, Susan
Liu, Hao
Volgina, Alla
Zolotarjova, Nina
Kapilashrami, Kanishk
Behshad, Elham
Covington, Maryanne
Yang, Yan-Ou
Li, Jingwei
Diamond, Sharon
Soloviev, Maxim
O'Hayer, Kevin
Rubin, Stephen
Kanellopoulou, Chrysi
Yang, Gengjie
Rupar, Mark
DiMatteo, Darlise
Lin, Luping
Stevens, Christina
Zhang, Yue
Thekkat, Pramod
Geschwindt, Ryan
Marando, Cindy
Yeleswaram, Swamy
Jackson, Jeff
Scherle, Peggy
Huber, Reid
Yao, Wenqing
Hollis, Gregory
CANCER DISCOVERY, 2022, 12 (06) : 1482 - 1499
[26] Novel, brain penetrant small molecule inhibitor of PD-L1 for targeting glioblastoma and brain metastasis
Dhanalakshmi, S.
Rajagopal, S.
Gajendran, C.
Sadhu, M. N.
Zainuddin, M.
Gosu, R.
Rastelli, L.
EUROPEAN JOURNAL OF CANCER, 2022, 174 : S125 - S125
[27] BPI-23314: A novel orally bioavailable small molecular BET inhibitor with target protein degradation activity
Guo, Jing
Xu, Yan
Yan, Dan
Yu, Bo
Yu, Weiwei
Chen, Haibo
Xu, Xiaofeng
Liu, Xiangyong
Lan, Hong
Ding, Lieming
Wang, Jiabing
CANCER RESEARCH, 2020, 80 (16)
[28] Progress in small-molecule inhibitors targeting PD-L1
Xu, Jindan
Kong, Yuanfang
Zhu, Pengbo
Du, Mingyan
Liang, Xuan
Tong, Yan
Li, Xiaofei
Dong, Chunhong
RSC MEDICINAL CHEMISTRY, 2024, 15 (04): : 1161 - 1175
[29] Discovery and characterization of a novel small molecule antagonist of PD-L1
Ying, Haiyan
Yang, Fei
Zhang, Mingming
Zhang, Yongxian
Zhao, Yuan
Chen, Xin
Zhang, Lei
Yu, Hongping
Chen, Zhui
Xu, Yao-chang
MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
[30] Comprehensive in vitro characterization of PD-L1 small molecule inhibitors
Ganesan, Aravindhan
Ahmed, Marawan
Okoye, Isobel
Arutyunova, Elena
Babu, Dinesh
Turnbull, William L.
Kundu, Joydeb Kumar
Shields, Justin
Agopsowicz, Katharine Cheryl
Xu, Lai
Tabana, Yasser
Srivastava, Nutan
Zhang, Guangzhi
Moon, Tae Chul
Belovodskiy, Alexandr
Hena, Mostofa
Kandadai, Appan Srinivas
Hosseini, Seyedeh N. Argess
Hitt, Mary
Walker, John
Smylie, Michael
West, Frederick G.
Siraki, Arno G.
Lemieux, M. Joanne
Elahi, Shokrollah
Nieman, James A.
Tyrrell, D. Lorne
Houghton, Michael
Barakat, Khaled
SCIENTIFIC REPORTS, 2019, 9 (1)

← 1 2 3 4 5 →